GB2379608A - Liquid ventilation for the removal of chemicals - Google Patents
Liquid ventilation for the removal of chemicals Download PDFInfo
- Publication number
- GB2379608A GB2379608A GB0122499A GB0122499A GB2379608A GB 2379608 A GB2379608 A GB 2379608A GB 0122499 A GB0122499 A GB 0122499A GB 0122499 A GB0122499 A GB 0122499A GB 2379608 A GB2379608 A GB 2379608A
- Authority
- GB
- United Kingdom
- Prior art keywords
- liquid
- chemicals
- ventilation
- breathable
- lipophilic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/02—Halogenated hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention relates to a method of removing lipophilic chemicals dissolved in the cellular membranes of the pulmonary tissue by use of the method known as liquid ventilation in which a breathable liquid capable of dissolving gases is added to the lung to allow respiration even though the lung has liquid in it. The lipophilic nature of the breathable liquids allows them to dissolve lipophilic chemicals, thus allowing for passive partitioning of lipophilic chemicals between the lipophilic environment of the cellular membranes and the breathable liquid. Continued liquid ventilation allows chemicals to be leached from the cellular membranes and removed from the pulmonary tissue. The preferred agent is perflubron (perfluorooctylbromide).
Description
<Desc/Clms Page number 1>
IMPROVEMENTS IN OR RELATING TO THE REMOVAL OF CHEMICALS
The invention relates to the use of liquid ventilation for the removal of chemicals from cellular membranes of the lung tissue.
It is known that chemicals of a lipophilic nature can accumulate in the hydrophobic environment of the cellular membranes. Many of the chemicals known to contribute to the risk of cancer are of a lipophilic nature. Some of the chemicals in tobacco smoke are known to be lipophilic in nature, in that they are poorly soluble in water. It is known that some of these chemicals, for instance the class of compounds known as polycyclic aromatic hydrocarbons, are very poorly soluble in water. Experiments to find out the mechanism of how these chemicals enter the cells have shown that they partition passively into the membranes of cells. This passive partitioning is related to their lipophilic nature. This passive diffusion is a process of passive partitioning governed by the relative volumes and solubility properties of the various environments within the lungs.
Accumulated chemicals in the membranes constitute a reservoir of carcinogenic potential, in that they may eventually be activated by the detoxifying mechanisms of the body, into carcinogens, or co-carcinogens.
These accumulated chemicals are known to stay in the body for years even after cessation of smoking.
In view of this accumulated residual reservoir of carcinogenic chemicals, the present invention discloses a method of removing a fraction of the chemicals by the method of liquid ventilation. Liquid ventilation may be performed with a large number of liquids such as
<Desc/Clms Page number 2>
perfluorocarbons, silicone liquids, saline, vegetable oils. Many of the chemicals used for liquid ventilation are of a lipophilic nature, this intrinsic property allows them to be solvents for other lipophilic chemicals.
The main environmental risk factor associated with lung cancer is the inhalation of tobacco smoke. Tobacco smoke is a complex mixture of chemicals and particulate matter. The carbonaceous particles that collect within the lung tissue carry dissolved chemicals within them.
These chemicals rapidly dissolve into the mucous lining layer of the lungs, and can then dissolve into the cellular membranes. Once in the cellular membranes Lhey may reside for several years before being removed.
Within tobacco smoke there are several chemicals which are known to be carcinogenic, they may include procarcinogens, co-carcinogens or carcinogens.
Pro-carcinogens need to be enzymatically activated by the bodies detoxifying enzymes before they become carcinogenic. Co-carcinogens may only increase the risk of cancer when present with other chemicals or carcinogenic agents. Carcinogens can have direct mutational effects as soon as they come in contact with cellular DNA.
In the liquid ventilation described a breathable liquid capable of dissolving gases is added to the lung to allow respiration even though the lung has liquid in it. The lipophilic nature of the breathable liquids allows them to dissolve lipophilic chemicals, thus allowing for passive partitioning of lipophilic chemicals between the lipophilic environment of the cellular membranes and the breathable liquid. Continued liquid
<Desc/Clms Page number 3>
ventilation allows chemicals to be leached from the cellular membranes and removed from the pulmonary tissue.
Claims (19)
- CLAIMS: 1. The use of liquid ventilation for the removal of chemicals from the cellular membranes of the pulmonary, trachea, bronchi, bronchioles or alveoli tissue.
- 2. The method of claim 1, wherein the liquid ventilation is performed with a liquid selected from the group consisting of perfluorocarbon liquids or saline or silicone liquids or vegetable oils and combinations thereof.
- 3. The method of claim 1, wherein the liquid ventilation is performed with perfluorooctylbromide.
- 4 U 4 4. The method of claim 1, wherein the liquid ventilation is performed with perfluorodecalin.
- 5. The method of any of the preceding claims, wherein the ventilating liquid is heated to above body temperature.
- 6. The method of any of the preceding claims, wherein the liquid ventilation is tidal.
- 7. The method of any of the preceding claims, wherein the liquid ventilation is partial.
- 8. A method for the removal of chemicals resident in the pulmonary cellular membranes, the method comprising the step of introducing a breathable liquid into the lung of the patient, the said liquid being capable of use as a liquid ventilating medium.
- 9. The method of claim 8, further comprising the step of heating the said breathable liquid prior to this introduction into the lung.
- 10. The method of claim 8 or claim 9, wherein the said breathable liquid is chosen from the group consisting of perfluorocarbon/fluorocarbon or<Desc/Clms Page number 5>silicone liquids, vegetable oils, saline and combinations thereof.
- 11. The method of claim 10, wherein the perfluorocarbon liquid is perfluorooctylbromide.
- 12. A method for the removal or extraction of lipophilic chemicals from the pulmonary cellular membranes using liquid ventilation or breathable liquids.
- 13. The method of claim 12, wherein said liquid ventilation is tidal.
- 14. The method of claim 12, wherein said liquid ventilation is partial.
- 15. The method of any of claims 12 to 14, wherein said liquid ventilation is performed with a liquid chosen from the group consisting of fluorocarbon or silicone liquids, vegetable oils, saline or combinations thereof.
- 16. The method of claim 15, wherein said fluorocarbon is perfluorooctylbromide.
- 17. The method of claim 15, wherein said fluorocarbon is perfluorodecaline.
- 18. The method of any of claims 12 to 17, wherein the breathable liquid is heated to above body temperature.
- 19. The method of any of claims 12 to 18, wherein the liquid is removed.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0122499A GB2379608A (en) | 2001-09-18 | 2001-09-18 | Liquid ventilation for the removal of chemicals |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0122499A GB2379608A (en) | 2001-09-18 | 2001-09-18 | Liquid ventilation for the removal of chemicals |
Publications (2)
Publication Number | Publication Date |
---|---|
GB0122499D0 GB0122499D0 (en) | 2001-11-07 |
GB2379608A true GB2379608A (en) | 2003-03-19 |
Family
ID=9922286
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0122499A Withdrawn GB2379608A (en) | 2001-09-18 | 2001-09-18 | Liquid ventilation for the removal of chemicals |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2379608A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2422310A (en) * | 2004-12-02 | 2006-07-26 | Kaizen Matsumoto | Perfluorocarbon solvents for reducing the concentration of carcinogens in cells |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991003267A1 (en) * | 1989-08-28 | 1991-03-21 | Sekins K Michael | Lung cancer hyperthermia via ultrasound and/or convection with perfluorocarbon liquids |
WO1992019232A1 (en) * | 1991-05-03 | 1992-11-12 | Alliance Pharmaceutical Corp. | Partial liquid breathing of fluorocarbons |
WO1993009833A1 (en) * | 1991-11-14 | 1993-05-27 | Alliance Pharmaceutical Corp. | Method and apparatus for partial liquid ventilation using fluorocarbons |
WO1998016210A1 (en) * | 1996-10-15 | 1998-04-23 | Sonus Pharmaceuticals, Inc. | Fluorocarbon-containing agents for pulmonary lavage and drug delivery |
-
2001
- 2001-09-18 GB GB0122499A patent/GB2379608A/en not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991003267A1 (en) * | 1989-08-28 | 1991-03-21 | Sekins K Michael | Lung cancer hyperthermia via ultrasound and/or convection with perfluorocarbon liquids |
WO1992019232A1 (en) * | 1991-05-03 | 1992-11-12 | Alliance Pharmaceutical Corp. | Partial liquid breathing of fluorocarbons |
WO1993009833A1 (en) * | 1991-11-14 | 1993-05-27 | Alliance Pharmaceutical Corp. | Method and apparatus for partial liquid ventilation using fluorocarbons |
WO1998016210A1 (en) * | 1996-10-15 | 1998-04-23 | Sonus Pharmaceuticals, Inc. | Fluorocarbon-containing agents for pulmonary lavage and drug delivery |
Non-Patent Citations (1)
Title |
---|
Abstract NLM10981579 & Acta Anaesth. Scand., 44(8), 994-1001, (2000) * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2422310A (en) * | 2004-12-02 | 2006-07-26 | Kaizen Matsumoto | Perfluorocarbon solvents for reducing the concentration of carcinogens in cells |
WO2006059063A3 (en) * | 2004-12-02 | 2006-12-21 | Kaizen Robert Matsumoto | Perfluorocarbon liquids as carcinogen |
GB2422310B (en) * | 2004-12-02 | 2006-12-27 | Kaizen Matsumoto | Carcinogen solvents in reducing the carcinogen concentration of cells |
Also Published As
Publication number | Publication date |
---|---|
GB0122499D0 (en) | 2001-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kehe et al. | Medical aspects of sulphur mustard poisoning | |
Traber et al. | The pathophysiology of inhalation injury | |
Benson et al. | Lung disease induced by drug addiction. | |
Tomashefski Jr et al. | The pulmonary pathology of illicit drug and substance abuse | |
Goldring et al. | Pulmonary Effects of Sulfur Dioxide Exposure in the Syrian Hamster: I. Combined With Viral Respiratory Disease | |
Ruhl et al. | A serious skin sulfur mustard burn from an artillery shell | |
CN105852208B (en) | A kind of smoke filtration liquid and its preparation method and application in cigaratte filter | |
McKay | Toxin-induced respiratory distress | |
GB2379608A (en) | Liquid ventilation for the removal of chemicals | |
Helden van et al. | Asthmalike symptoms following intratracheal exposure of Guinea pigs to sulfur mustard aerosol: therapeutic efficacy of exogenous lung surfactant curosurf and salbutamol | |
Malinverno et al. | Toxicological profile of hydrofluoropolyethers | |
Swiecichowski et al. | Formaldehyde-induced airway hyperreactivity in vivo and ex vivo in guinea pigs | |
Bakovic et al. | Suicidal chemistry: combined intoxication with carbon monoxide and formic acid | |
Kleinman | The health effects of air pollution on children | |
Ghanei et al. | Mustard lung: diagnosis and treatment of respiratory disorders in sulfur-mustard injured patients | |
Gislason | Air and Breathing | |
Zolghadri et al. | Short-term and long-term health problems in exposure to chemicals | |
Berkmen | Aspiration and inhalation pneumonias | |
Dang et al. | Chemical warfare agents | |
Kolecki et al. | Inhalant abuse | |
Williams | Breathing: An Inspired History | |
Witschi | Tobacco toxicology revisited | |
Garcia | B1 ACETONE | |
Chu | Burns updated in China: II. Special burn injury and burns of special areas | |
CN2243787Y (en) | Magnet filter anti-cancer cigarette holder |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |